MetaCap

Sarepta Therapeutics Insider Trades

NASDAQ: SRPTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

17.85-0.36 (-1.98%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

After hours: 17.95 +0.56%

Last 12 months

Purchases
0 · $0
Sales
2 · $417.41K
Shares bought / sold
0 / 20.43K
Net activity
Net selling $417,410

Sarepta Therapeutics insider activity

Over the last 12 months, Sarepta Therapeutics insiders reported 50 transactions on SEC Form 4: 0 open-market purchases and 2 sales. Insiders bought $0 and sold $417,410 worth of stock, for net insider selling of $417,410. The largest seller was Estepan Ian Michael, with $294,202 in reported sales.

The most recent filing shows Rothfuss Cristin (EVP, General Counsel) reporting a transaction in 22,025 shares at $22.22 on Sep 4, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SRPT's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

SRPT insider transactions

Sarepta Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 4, 2026Estepan Ian MichaelChief Operating OfficerTax withholding24,799$551.03KForm 4
Sep 4, 2026Wong Ryan Ho-YanChief Financial OfficerTax withholding13,272$294.90KForm 4
Sep 4, 2026Rodino-Klapac LouisePresident, R&D and Tech OpsTax withholding21,423$476.02KForm 4
Sep 4, 2026Rothfuss CristinEVP, General CounselTax withholding22,025$489.40KForm 4
Jul 28, 2026SEVERINO MICHAELChief Executive OfficerAward756,104—Form 4
Jun 4, 2026Chambers Michael AndrewDirectorAward16,875—Form 4
Jun 4, 2026Wigzell Hans Lennart RudolfDirectorAward16,875—Form 4
Jun 4, 2026Boor Kathryn JeanDirectorAward16,875—Form 4
Jun 4, 2026Barry RichardDirectorAward16,875—Form 4
Jun 4, 2026Nicaise ClaudeDirectorAward16,875—Form 4
Jun 4, 2026Connelly Deirdre PDirectorAward16,875—Form 4
Jun 4, 2026BEHRENS M KATHLEENDirectorAward16,875—Form 4
Jun 4, 2026Mayo StephenDirectorAward16,875—Form 4
Mar 12, 2026Mayo StephenDirectorSale7,239$123.21KForm 4
Mar 11, 2026Wong Ryan Ho-YanChief Financial OfficerTax withholding256$4.36KForm 4
Mar 11, 2026Estepan Ian MichaelChief Operating OfficerTax withholding1,097$18.68KForm 4
Mar 11, 2026Rothfuss CristinEVP, General CounselTax withholding974$16.59KForm 4
Mar 11, 2026Rodino-Klapac LouisePresident, R&D and Tech OpsTax withholding948$16.14KForm 4
Mar 9, 2026Estepan Ian MichaelChief Operating OfficerTax withholding583$9.88KForm 4
Mar 9, 2026Estepan Ian MichaelChief Operating OfficerTax withholding1,036$17.56KForm 4
Mar 9, 2026Rodino-Klapac LouisePresident, R&D and Tech OpsTax withholding895$15.17KForm 4
Mar 9, 2026Rodino-Klapac LouisePresident, R&D and Tech OpsTax withholding504$8.54KForm 4
Mar 9, 2026Wong Ryan Ho-YanChief Financial OfficerTax withholding113$1.92KForm 4
Mar 9, 2026Wong Ryan Ho-YanChief Financial OfficerTax withholding162$2.75KForm 4
Mar 9, 2026Rothfuss CristinEVP, General CounselTax withholding346$5.86KForm 4
Mar 9, 2026Rothfuss CristinEVP, General CounselTax withholding484$8.20KForm 4
Mar 2, 2026Rodino-Klapac LouisePresident, R&D and Tech OpsTax withholding767$12.43KForm 4
Mar 2, 2026Rodino-Klapac LouisePresident, R&D and Tech OpsTax withholding3,718$60.23KForm 4
Mar 2, 2026Estepan Ian MichaelChief Operating OfficerTax withholding875$14.18KForm 4
Mar 2, 2026Estepan Ian MichaelChief Operating OfficerTax withholding3,301$53.48KForm 4
Mar 2, 2026Wong Ryan Ho-YanChief Financial OfficerTax withholding450$7.29KForm 4
Mar 2, 2026Rothfuss CristinEVP, General CounselTax withholding408$6.61KForm 4
Mar 1, 2026Rodino-Klapac LouisePresident, R&D and Tech OpsOption exercise8,125—Form 4
Mar 1, 2026Estepan Ian MichaelChief Operating OfficerOption exercise8,125—Form 4
Feb 26, 2026Estepan Ian MichaelChief Operating OfficerOption exercise5,381$73.77KForm 4
Feb 26, 2026Estepan Ian MichaelChief Operating OfficerOption exercise2,069$28.37KForm 4
Jan 29, 2026Nicaise ClaudeDirectorTax withholding6,780$143.94KForm 4
Jan 29, 2026Nicaise ClaudeDirectorOption exercise10,500$143.96KForm 4
Jan 27, 2026BEHRENS M KATHLEENDirectorTax withholding6,494$143.97KForm 4
Jan 27, 2026BEHRENS M KATHLEENDirectorOption exercise10,500$143.96KForm 4
Dec 16, 2025Estepan Ian MichaelChief Operating OfficerSale13,187$294.20KForm 4
Dec 7, 2025INGRAM DOUGLAS SChief Executive OfficerAward269,542—Form 4
Dec 7, 2025INGRAM DOUGLAS SChief Executive OfficerAward96,541—Form 4
Dec 7, 2025INGRAM DOUGLAS SChief Executive OfficerAward73,001—Form 4
Dec 7, 2025INGRAM DOUGLAS SChief Executive OfficerAward50,000—Form 4
Dec 7, 2025INGRAM DOUGLAS SChief Executive OfficerAward50,000—Form 4
Dec 1, 2025Wong Ryan Ho-YanChief Financial OfficerTax withholding78$1.63KForm 4
Dec 1, 2025Wong Ryan Ho-YanChief Financial OfficerTax withholding80$1.68KForm 4
Nov 28, 2025Rothfuss CristinEVP, General CounselTax withholding229$4.84KForm 4
Nov 17, 2025Rodino-Klapac LouisePresident, R&D and Tech OpsTax withholding4,582$84.40KForm 4
Sep 3, 2025Wong Ryan Ho-YanChief Financial OfficerAward25,000—Form 4
Sep 3, 2025Wong Ryan Ho-YanChief Financial OfficerAward93,875—Form 4
Sep 3, 2025Estepan Ian MichaelChief Operating OfficerAward50,000—Form 4
Sep 3, 2025Estepan Ian MichaelChief Operating OfficerAward93,875—Form 4
Sep 3, 2025Rodino-Klapac LouisePresident, R&D and Tech OpsAward50,000—Form 4
Sep 3, 2025Rodino-Klapac LouisePresident, R&D and Tech OpsAward93,875—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related